Detalhe da pesquisa
1.
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC.
Hepatology
; 2024 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38537130
2.
Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma.
Brief Bioinform
; 23(6)2022 11 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36136350
3.
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Mol Cancer
; 22(1): 159, 2023 10 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37784082
4.
Glioma targeted therapy: insight into future of molecular approaches.
Mol Cancer
; 21(1): 39, 2022 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35135556
5.
The causal effect of air pollution on the risk of essential hypertension: a Mendelian randomization study.
Front Public Health
; 12: 1247149, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38425468
6.
The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma.
Heliyon
; 10(1): e23915, 2024 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38205335
7.
Patient-derived xenograft models in cancer therapy: technologies and applications.
Signal Transduct Target Ther
; 8(1): 160, 2023 04 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37045827
8.
RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis.
Front Immunol
; 14: 1086280, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36776876
9.
ROS-scavenging nanomedicine for "multiple crosstalk" modulation in non-alcoholic fatty liver disease.
Biomater Sci
; 11(10): 3709-3725, 2023 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37039546
10.
An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms.
Cell Prolif
; 56(4): e13409, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36822595
11.
A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.
iScience
; 26(9): 107722, 2023 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37694141
12.
Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.
Front Immunol
; 13: 833792, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35418980
13.
A Novel Thrombosis-Related Signature for Predicting Survival and Drug Compounds in Glioblastoma.
J Oncol
; 2022: 6792850, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35874629
14.
Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.
Front Immunol
; 13: 931433, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35720317
15.
Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets.
Front Immunol
; 13: 907182, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36389798
16.
Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer.
Front Immunol
; 13: 810471, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35464411
17.
Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis.
Front Cell Dev Biol
; 10: 821649, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35493077
18.
PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma.
CNS Neurosci Ther
; 28(11): 1748-1766, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35855654
19.
Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role.
Biomed Pharmacother
; 156: 113783, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36240615
20.
Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma.
Theranostics
; 12(13): 5931-5948, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35966587